Effect of amoxycillin with or without clavulanate on adenoid bacterial flora

I Brook1, K Shah

  • 1Department of Pediatrics, Georgetown University, Washington, DC, USA. dribrook@yahoo.com

Insights

Antibiotic therapy with amoxycillin or co-amoxiclav significantly reduced adenoid bacteria in children with recurrent otitis media. Co-amoxiclav was most effective in lowering bacterial load, potential pathogens, and beta-lactamase-producing bacteria.

Area of Science:

  • Otolaryngology
  • Microbiology
  • Pharmacology

Background:

  • Recurrent otitis media (ROM) in children is often associated with adenoid bacterial colonization.
  • Understanding the impact of antibiotic therapy on this flora is crucial for treatment strategies.

Purpose of the Study:

  • To evaluate the effect of amoxycillin (AMX) and co-amoxiclav (AMC) on adenoid bacterial flora in children with ROM undergoing adenoidectomy.

Main Methods:

  • 45 children with ROM were randomized into three groups: no antibiotic, AMX, or AMC therapy for 10 days prior to surgery.
  • Core adenoid tissues were quantitatively cultured for aerobic and anaerobic bacteria.

Main Results:

  • Both AMX and AMC significantly reduced the total number of bacterial isolates compared to the control group.
  • Co-amoxiclav (AMC) demonstrated a greater reduction in potential pathogens and beta-lactamase-producing bacteria (BLPB) compared to amoxycillin (AMX) and the control group.
  • Polymicrobial flora, including common aerobes and anaerobes, was present in all children.

Conclusions:

  • Amoxycillin and co-amoxiclav effectively reduce bacterial load in adenoids of children with recurrent otitis media.
  • Co-amoxiclav shows superior efficacy in reducing potential pathogens and beta-lactamase-producing bacteria, suggesting a role in managing complex cases.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...